Andreas Palmborg

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Journal: Expert review of vaccines
Published: July 01, 2026

Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for maternal vaccination in Sweden: cost-effectiveness and budget impact.

Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for maternal vaccination in Sweden: cost-effectiveness and budget impact.

Journal: Journal of medical economics
Published: June 08, 2026

Trends in Hospitalisations Due to Respiratory Syncytial Virus in Swedish Children: A Nationwide Study 2010-2022.

Trends in Hospitalisations Due to Respiratory Syncytial Virus in Swedish Children: A Nationwide Study 2010-2022.

Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: November 27, 2025

Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for older adults in Sweden: cost-effectiveness and budget impact.

Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for older adults in Sweden: cost-effectiveness and budget impact.

Journal: Journal of medical economics
Published: October 25, 2025

Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022.

Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022.

Journal: Scientific reports
Published: October 14, 2024

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population.

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population.

Journal: Human vaccines & immunotherapeutics
Published: September 16, 2024

Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics.

Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics.

Journal: PloS one
Published: November 22, 2022

Recommendations to Improve Tick-Borne Encephalitis Surveillance and Vaccine Uptake in Europe.

Recommendations to Improve Tick-Borne Encephalitis Surveillance and Vaccine Uptake in Europe.

Journal: Microorganisms
Published: May 20, 2022

Acceptance and application of a broad population health perspective when evaluating vaccine.

Acceptance and application of a broad population health perspective when evaluating vaccine.

Journal: Vaccine
Published: December 16, 2021

TBE Vaccination Breakthrough Cases-Does Age Matter?

TBE Vaccination Breakthrough Cases-Does Age Matter?

Journal: Vaccines
Published: June 11, 2021

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014.

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014.

Journal: PloS one
Published: September 02, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026